Chromocell Therapeutics Corporation (CHRO)
USD 0.59
(-4.76%)
USD 0.59
(-4.76%)
| Breakdown | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Operating Cash Flow | -981.03 Thousand | -1.56 Million | -1.59 Million | -3.62 Million |
| Net Income | -7.38 Million | -2.45 Million | -595.38 Thousand | -660.58 Thousand |
| Depreciation & Amortization | 188.11 Thousand | - | - | - |
| Deferred income taxes | - | - | - | - |
| Stock-based compensation | 3.95 Million | 110.14 Thousand | - | - |
| Change in working capital | 2.05 Million | 640.86 Thousand | -755.83 Thousand | -2.96 Million |
| Other non-cash items | 2.72 Million | -163.02 Thousand | 585.91 Thousand | 2.96 Million |
| Investing Cash Flow | - | - | - | - |
| Investments in PPE | 1.00 | - | - | - |
| Acquisitions | - | - | - | - |
| Investment purchases | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - |
| Other Investing Activities | - | - | - | - |
| Financing Cash Flow | 1.02 Million | 1.62 Million | 1.59 Million | 3.62 Million |
| Debt repayment | -766.93 Thousand | -400 Thousand | -1.09 Million | -241.79 Thousand |
| Dividends payments | - | - | - | - |
| Common Stock Repurchased | - | - | - | - |
| Common Stock Issuance | 255.41 Thousand | - | - | - |
| Other Financing Activities | 1.02 Million | 1.22 Million | 1.59 Million | 3.38 Million |
| Accounts receivables | - | - | - | - |
| Accounts payables | 1.62 Million | 413.6 Thousand | -827.7 Thousand | -2.96 Million |
| Inventory | - | - | - | - |
| Other working capital | 424.07 Thousand | 227.26 Thousand | 71.87 Thousand | - |
| Cash at beginning of period | 55.07 Thousand | - | - | - |
| Cash at end of period | 96.39 Thousand | 55.07 Thousand | - | - |
| Capital Expenditure | 1.00 | - | - | - |
| Effect of forex changes on cash | - | - | - | - |
| Net cash flow / Change in cash | 41.31 Thousand | 55.07 Thousand | - | - |
| Free Cash Flow | -981.03 Thousand | -1.56 Million | -1.59 Million | -3.62 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.77 Million | -2.56 Million | -7.38 Million | -4.03 Million | -1.42 Million | -953.34 Thousand |
| Depreciation & Amortization | - | 605.63 Thousand | 188.11 Thousand | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 458.97 Thousand | 292.55 Thousand | 3.95 Million | 2.81 Million | 418.03 Thousand | 453.33 Thousand |
| Change in working capital | -1.63 Million | -327.74 Thousand | 2.05 Million | 544.03 Thousand | 728.8 Thousand | 288.91 Thousand |
| Other non-cash items | 2.03 Million | 807.18 Thousand | 2.72 Million | 2.67 Million | 435.69 Thousand | 470.81 Thousand |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | -5.00 | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 1.58 Million | 5.66 Million | 1.02 Million | 430.41 Thousand | 198.12 Thousand | 226.9 Thousand |
| Debt repayment | -1.58 Million | -214.75 Thousand | -766.93 Thousand | -175 Thousand | -198.12 Thousand | -226.9 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -91.51 Thousand | - | - | - | - |
| Common Stock Issuance | - | 5.97 Million | 255.41 Thousand | 255.41 Thousand | - | - |
| Other Financing Activities | 1.58 Million | -91.51 Thousand | 1.02 Million | 430.41 Thousand | 198.12 Thousand | 226.9 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -1.57 Million | 90.99 Thousand | 1.62 Million | 460.12 Thousand | 618.58 Thousand | 180.97 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -67.66 Thousand | -418.73 Thousand | 424.07 Thousand | 83.91 Thousand | -438.07 Thousand | 656.24 Thousand |
| Cash at beginning of period | 3.77 Million | 96.39 Thousand | 55.07 Thousand | 22.78 Thousand | 81.89 Thousand | 48.6 Thousand |
| Cash at end of period | 2.4 Million | 3.77 Million | 96.39 Thousand | 96.39 Thousand | 22.78 Thousand | 81.89 Thousand |
| Capital Expenditure | -5.00 | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -1.36 Million | 3.67 Million | 41.31 Thousand | 73.6 Thousand | -59.1 Thousand | 33.28 Thousand |
| Free Cash Flow | -2.95 Million | -1.99 Million | -981.03 Thousand | -356.8 Thousand | -257.23 Thousand | -193.62 Thousand |
4AB
BAJAJHLDNG
HENG
SAAM
PRM
CIM-PA